Aethlon Medical
AEMD Nasdaq
SEC CIK 882291 LEI 54930036LMXCIW3XG337
Follow Aethlon Medical
Weekly email: filings, results
Net income
−$2.6M
−76% vs same quarter last year
EPS, diluted
−$2.60
Operating cash flow
−$1.7M
−4.7% vs same quarter last year
Operating income
−$2.7M
−77.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | - | −$7.2M |
| FY25 | - | −$13.4M |
| FY24 | $0 | −$12.2M |
| FY23 | $574.2K | −$12M |
| FY22 | $294.2K | −$10.4M |
| FY21 | $659.1K | −$7.9M |
| FY20 | $650.2K | −$6.4M |
| FY19 | $229.6K | −$6.2M |
| FY18 | $149.6K | −$5.7M |
| FY17 | $392.1K | −$7.3M |
| FY16 | $886.6K | −$4.9M |
| FY15 | $762.4K | −$6.8M |
| FY14 | $1.6M | −$13.4M |
| FY13 | $1.2M | −$4.9M |
| FY12 | $1.4M | −$8.1M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY26 | - | - |
| FY25 | - | - |
| FY24 | - | - |
| FY23 | −2072% | −2094.9% |
| FY22 | −3542.5% | −3540.9% |
| FY21 | −1197.3% | −1196.6% |
| FY20 | −912% | −980.3% |
| FY19 | −2612.5% | −2697.8% |
| FY18 | −3228.8% | −3795.9% |
| FY17 | −1555.4% | −1855.8% |
| FY16 | −494.6% | −549.6% |
| FY15 | −523.7% | −891.5% |
| FY14 | −188.2% | −822.6% |
| FY13 | −290.7% | −397.7% |
| FY12 | −229.1% | −596.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$7M |
| FY25 | −$7.6M |
| FY24 | −$10.4M |
| FY23 | −$11.4M |
| FY22 | −$10.1M |
| FY21 | −$6.8M |
| FY20 | −$5.3M |
| FY19 | −$4.3M |
| FY18 | −$3.9M |
| FY17 | −$3.5M |
| FY16 | −$4.3M |
| FY15 | −$5M |
| FY14 | −$2.2M |
| FY13 | −$2.1M |
| FY12 | −$1.8M |
- Aethlon Medical
- Healthcare median
Show the numbers
| Year | Aethlon Medical | Healthcare median |
|---|---|---|
| FY26 | - | −11.1% |
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | −2094.9% | −58% |
| FY22 | −3540.9% | −80.4% |
| FY21 | −1196.6% | −71.8% |
| FY20 | −980.3% | −62.2% |
| FY19 | −2697.8% | −46.2% |
| FY18 | −3795.9% | −49.6% |
| FY17 | −1855.8% | −45.9% |
| FY16 | −549.6% | −36% |
| FY15 | −891.5% | −37.8% |
| FY14 | −822.6% | −35.5% |
| FY13 | −397.7% | −37.1% |
| FY12 | −596.6% | −29.1% |